Article
Genetic variants in anti-Müllerian hormone-related genes and breast cancer risk: results from the AMBER consortium.
Breast cancer research and treatment - 1 Jan 2021
Nichols Hazel B, Graff Mariaelisa, Bensen Jeannette T, Lunetta Kathryn L, O'Brien Katie M, Troester Melissa A, Williams Lindsay A, Young Kristin, Hong Chi-Chen, Yao Song, Haiman Christopher A, Ruiz-Narváez Edward A, Ambrosone Christine B, Palmer Julie R, Olshan Andrew F
Abstract excerpt
PURPOSE: Circulating anti-Müllerian hormone (AMH) levels are positively associated with time to menopause and breast cancer risk. We examined breast cancer associations with single nucleotide polymorphisms (SNPs) in the AMH gene or its receptor genes, ACVR1 and AMHR2, among African American women. METHODS: In the AMBER consortium, we tested 65 candidate SNPs, and 1130 total variants, in or near AMH, ACVR1, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
